|
US3740412A
(en)
|
1970-04-08 |
1973-06-19 |
Synvar Ass |
Imidazoline-3-oxide-1-oxyl derivatives
|
|
US3997223A
(en)
|
1975-04-30 |
1976-12-14 |
Dynascan Corporation |
Apparatus and method for rejuvenating cathode ray tubes
|
|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4267333A
(en)
|
1979-09-26 |
1981-05-12 |
Union Carbide Agricultural Products Company, Inc. |
Preparation of 2-trifluoromethyl cinchoninic acids
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
US4435419A
(en)
|
1981-07-01 |
1984-03-06 |
American Cyanamid Company |
Method of treating depression using azabicyclohexanes
|
|
US4431661A
(en)
|
1981-08-20 |
1984-02-14 |
American Cyanamid Company |
5-Aryl-3-azabicyclo[3.2.0]heptan-6-one acetals, and analgesic use therefor
|
|
AU534404B2
(en)
|
1981-09-01 |
1984-01-26 |
American Cyanamid Company |
Cyclopropane derivatives
|
|
US4490055A
(en)
|
1982-06-30 |
1984-12-25 |
International Business Machines Corporation |
Automatically adjustable delay function for timed typamatic
|
|
US4544665A
(en)
|
1983-11-21 |
1985-10-01 |
American Cyanamid Company |
1-Aryl-3-azabicyclo[3.2.0]heptanes
|
|
GB2200628A
(en)
|
1987-02-06 |
1988-08-10 |
Shell Int Research |
Diphenyl ether herbicides
|
|
US5089633A
(en)
|
1987-04-28 |
1992-02-18 |
Georgia Tech Research Corporation |
Substituted isocoumarins
|
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
|
JPH032797A
(ja)
|
1989-05-30 |
1991-01-09 |
Meidensha Corp |
音声合成装置の抑揚制御方式
|
|
WO1994000555A2
(en)
|
1992-06-25 |
1994-01-06 |
Cetus Oncology Corporation |
Compositions for the inhibition of protein hormone formation and uses thereof
|
|
US5120752A
(en)
|
1989-12-28 |
1992-06-09 |
Abbott Laboratories |
Cyclopropyl derivative lipoxygenase inhibitors
|
|
US5037853A
(en)
|
1989-12-28 |
1991-08-06 |
Abbott Laboratories |
Cyclopropyl derivative lipoxygenase inhibitors
|
|
US5114953A
(en)
|
1990-11-21 |
1992-05-19 |
University Of Florida |
Treatment for tissue ulceration
|
|
GB9102635D0
(en)
|
1991-02-07 |
1991-03-27 |
British Bio Technology |
Compounds
|
|
US5256657A
(en)
|
1991-08-19 |
1993-10-26 |
Sterling Winthrop, Inc. |
Succinamide derivative matrix-metalloprotease inhibitors
|
|
AU2807192A
(en)
|
1991-10-02 |
1993-05-03 |
Smithkline Beecham Corporation |
Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity
|
|
JPH05262698A
(ja)
|
1992-03-24 |
1993-10-12 |
Dainippon Ink & Chem Inc |
光学活性トリフルオロメチルシクロプロパン誘導体、その合成中間体、それを含む液晶組成物及び液晶表示素子
|
|
US5525629A
(en)
|
1992-04-07 |
1996-06-11 |
British Bio-Technology Limited |
Inhibition of cytokine production
|
|
US5674901A
(en)
|
1995-06-01 |
1997-10-07 |
Wisconsin Alumni Research Foundation |
Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
|
|
US5318964A
(en)
|
1992-06-11 |
1994-06-07 |
Hoffmann-La Roche Inc. |
Hydroxamic derivatives and pharmaceutical compositions
|
|
GB9215665D0
(en)
|
1992-07-23 |
1992-09-09 |
British Bio Technology |
Compounds
|
|
GB9223904D0
(en)
|
1992-11-13 |
1993-01-06 |
British Bio Technology |
Inhibition of cytokine production
|
|
US5646167A
(en)
|
1993-01-06 |
1997-07-08 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamix acids
|
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
US5552419A
(en)
|
1993-01-06 |
1996-09-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
US5506242A
(en)
|
1993-01-06 |
1996-04-09 |
Ciba-Geigy Corporation |
Arylsufonamido-substituted hydroxamic acids
|
|
CN1105799A
(zh)
|
1993-03-18 |
1995-07-26 |
大制药株式会社 |
作为基质金属蛋白酶抑制剂的喹诺酮衍生物
|
|
GB9307956D0
(en)
|
1993-04-17 |
1993-06-02 |
Walls Alan J |
Hydroxamic acid derivatives
|
|
JPH072797A
(ja)
|
1993-04-19 |
1995-01-06 |
Sankyo Co Ltd |
コラゲナーゼ阻害剤
|
|
GB9311282D0
(en)
*
|
1993-06-01 |
1993-07-21 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
|
FI960803L
(fi)
|
1993-08-23 |
1996-04-22 |
Immunex Corp |
TNF-alfa-sekreetion inhibiittoreita
|
|
US5594106A
(en)
|
1993-08-23 |
1997-01-14 |
Immunex Corporation |
Inhibitors of TNF-α secretion
|
|
GB9320660D0
(en)
|
1993-10-07 |
1993-11-24 |
British Bio Technology |
Inhibition of cytokine production
|
|
JP3297053B2
(ja)
|
1994-01-20 |
2002-07-02 |
ブリテッシュ バイオテック ファーマシューティカルズ リミテッド |
金属タンパク質分解酵素阻害剤
|
|
GB9401129D0
(en)
|
1994-01-21 |
1994-03-16 |
British Bio Technology |
Hydroxamic acid derivatives as metalloproteinase inhibitors
|
|
AU678884B2
(en)
|
1994-01-22 |
1997-06-12 |
British Biotech Pharmaceuticals Limited |
Metalloproteinase inhibitors
|
|
US5514716A
(en)
|
1994-02-25 |
1996-05-07 |
Sterling Winthrop, Inc. |
Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
|
|
WO1995024501A1
(en)
|
1994-03-07 |
1995-09-14 |
Cetus Oncology Corporation |
Compositions for the inhibition of tnf formation and uses thereof
|
|
GB9501737D0
(en)
|
1994-04-25 |
1995-03-22 |
Hoffmann La Roche |
Hydroxamic acid derivatives
|
|
WO1995029892A1
(en)
|
1994-04-28 |
1995-11-09 |
The Du Pont Merck Pharmaceutical Company |
Hydroxamic acid and amino acid derivatives and their use as anti-arthritic agents
|
|
US5817822A
(en)
|
1994-06-24 |
1998-10-06 |
Novartis Corporation |
Certain alpha-azacycloalkyl substituted arylsulfonamido acetohydroxamic acids
|
|
US5840698A
(en)
|
1994-10-27 |
1998-11-24 |
Affymax Technologies N.V. |
Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
|
|
JP2902318B2
(ja)
|
1994-12-28 |
1999-06-07 |
呉羽化学工業株式会社 |
エスクレチン誘導体、その製造方法及びマトリックスメタロプロテアーゼ阻害剤
|
|
US5703092A
(en)
|
1995-04-18 |
1997-12-30 |
The Dupont Merck Pharmaceutical Company |
Hydroxamic acid compounds as metalloprotease and TNF inhibitors
|
|
US5691381A
(en)
|
1995-04-18 |
1997-11-25 |
The Dupont Merck Pharmaceutical Company |
Hydroxamic and carbocyclic acids as metalloprotease inhibitors
|
|
US5880141A
(en)
|
1995-06-07 |
1999-03-09 |
Sugen, Inc. |
Benzylidene-Z-indoline compounds for the treatment of disease
|
|
GB2303130A
(en)
|
1995-07-10 |
1997-02-12 |
Secr Defence |
Cyclic oligomers of substituted cyclic ethers
|
|
GB9514867D0
(en)
|
1995-07-20 |
1995-09-20 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
KR980009238A
(ko)
|
1995-07-28 |
1998-04-30 |
우에노 도시오 |
설포닐아미노산 유도체
|
|
EP0848957A1
(en)
|
1995-09-08 |
1998-06-24 |
Kanebo Ltd. |
Fas LIGAND SOLUBILIZATION INHIBITOR
|
|
KR100472752B1
(ko)
|
1995-10-05 |
2006-01-27 |
다윈 디스커버리 리미티드 |
금속단백질 가수분해 효소 및 티엔에프 유리에 대한 억제제로서의 티오-치환펩티드
|
|
JP2000502050A
(ja)
|
1995-11-14 |
2000-02-22 |
ザ・デュポン・メルク・ファーマシュウティカル・カンパニー |
メタロプロテアーゼ阻害剤としての新規なマクロ環状化合物
|
|
US5665777A
(en)
|
1995-11-14 |
1997-09-09 |
Abbott Laboratories |
Biphenyl hydroxamate inhibitors of matrix metalloproteinases
|
|
NZ322553A
(en)
|
1995-11-23 |
1998-12-23 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
US5753653A
(en)
|
1995-12-08 |
1998-05-19 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
EA003294B1
(ru)
|
1995-12-08 |
2003-04-24 |
Агурон Фармасьютикалс, Инк. |
Ингибиторы металлопротеиназы, фармацевтические композиции, их содержащие, и их фармацевтические применения
|
|
TW453995B
(en)
|
1995-12-15 |
2001-09-11 |
Novartis Ag |
Certain alpha-substituted arylsulfonamido acetohydroxamic acids
|
|
DK0780386T3
(da)
|
1995-12-20 |
2003-02-03 |
Hoffmann La Roche |
Matrixmetalloproteaseinhibitorer
|
|
WO1997024117A1
(en)
|
1996-01-02 |
1997-07-10 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds
|
|
JPH09202774A
(ja)
*
|
1996-01-25 |
1997-08-05 |
Green Cross Corp:The |
2−アリールキノリン類およびその製造方法
|
|
TW448172B
(en)
|
1996-03-08 |
2001-08-01 |
Pharmacia & Upjohn Co Llc |
Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
|
|
WO1997040031A1
(en)
|
1996-04-23 |
1997-10-30 |
Pharmacia & Upjohn Company |
Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
|
|
WO1997042168A1
(en)
|
1996-05-06 |
1997-11-13 |
Zeneca Limited |
Thio derivatives of hydroxamic acids
|
|
IT1283637B1
(it)
|
1996-05-14 |
1998-04-23 |
Italfarmaco Spa |
Composti ad attivita' antinfiammatoria ed immunosoppressiva
|
|
WO1998002557A2
(en)
|
1996-07-12 |
1998-01-22 |
Schering Corporation |
MAMMALIAN TNF-α CONVERTASES
|
|
US5853977A
(en)
|
1996-07-12 |
1998-12-29 |
Schering Corporation |
Mammalian TNF-α convertases
|
|
EP0818442A3
(en)
|
1996-07-12 |
1998-12-30 |
Pfizer Inc. |
Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
|
|
EP0923585B1
(en)
|
1996-07-18 |
2002-05-08 |
Pfizer Inc. |
Phosphinate based inhibitors of matrix metalloproteases
|
|
ATE233552T1
(de)
|
1996-07-22 |
2003-03-15 |
Monsanto Co |
Thiol-sulfonen als metalloproteinaseinhibitoren
|
|
EP0922030A1
(en)
|
1996-08-23 |
1999-06-16 |
Pfizer Inc. |
Arylsulfonylamino hydroxamic acid derivatives
|
|
HUP0000505A3
(en)
|
1996-08-28 |
2001-12-28 |
Procter & Gamble |
Saturated 7-9 membered heterocyclic n-hydroxycarboxamide derivatives and pharmaceutical compositions containing them
|
|
CN1228771A
(zh)
|
1996-08-28 |
1999-09-15 |
普罗克特和甘保尔公司 |
1,3-二杂环金属蛋白酶抑制剂
|
|
HUP9903916A3
(en)
|
1996-08-28 |
2001-06-28 |
Procter And Gamble Co Cincinna |
Phosphinic acid amides and pharmaceutical compositions containing the same
|
|
ATE226573T1
(de)
|
1996-08-28 |
2002-11-15 |
Procter & Gamble |
Heterozyklische metalloproteaseinhibitoren
|
|
KR20000068415A
(ko)
|
1996-09-04 |
2000-11-25 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
매트릭스 메탈로프로테이나제 억제용 화합물 및 방법
|
|
KR100338610B1
(ko)
|
1996-09-04 |
2002-05-27 |
디. 제이. 우드, 스피겔 알렌 제이 |
인다졸 유도체 및 포스포디에스터라제 (pde) 유형 iv 및 종양괴사인자 (tnf) 생산의 억제제로서 그의 용도
|
|
PT928291E
(pt)
|
1996-09-19 |
2003-03-31 |
Aventis Pharma Inc |
Derivados de 3-mercaptoacetilamino-1,5-substituido-2-oxo-azepano uteis como inibidores de metaloproteinases matriciais
|
|
ID21897A
(id)
|
1996-09-27 |
1999-08-05 |
Upjohn Co |
Asam b-sulfonil hidroksamat sebagai bahan penghambat matriks metaloproteinase
|
|
WO1998015525A1
(en)
|
1996-10-07 |
1998-04-16 |
Sumitomo Pharmaceuticals Co., Ltd. |
Hydroxamic acids
|
|
DE69709160T2
(de)
|
1996-10-16 |
2002-08-14 |
American Cyanamid Co., Madison |
Herstellung und anwendung von ortho-sulfonamido-aryl-hydroxamsäuren als matrix-metalloproteinase- und tace-inhibitoren
|
|
KR20000049197A
(ko)
|
1996-10-16 |
2000-07-25 |
윌리암 에이취 캘넌, 에곤 이 버그 |
매트릭스 메탈로프로테이나제 및 종양 괴사 인자-α 전환 효소억제제로서의 오르토-설폰아미도 헤테로아릴 하이드록삼산의 제조 및 용도
|
|
US5962481A
(en)
|
1996-10-16 |
1999-10-05 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
US5977408A
(en)
|
1996-10-16 |
1999-11-02 |
American Cyanamid Company |
Preparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
NZ335053A
(en)
|
1996-10-16 |
2000-10-27 |
American Cyanamid Co |
Beta-sulfonamido hydroxamic acids or ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase MMP and TACE (tumour necrosis factor, TNF, alpha converting enzyme) inhibitors
|
|
US6548524B2
(en)
|
1996-10-16 |
2003-04-15 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
AU743901B2
(en)
|
1996-10-16 |
2002-02-07 |
Wyeth Holdings Corporation |
Ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloprote inase and tace inhibitors
|
|
GB9621814D0
(en)
|
1996-10-19 |
1996-12-11 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
US6008243A
(en)
|
1996-10-24 |
1999-12-28 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
|
|
MY117687A
(en)
|
1996-10-31 |
2004-07-31 |
Bayer Corp |
Substituted 4-biphenyl-4-hydroxybutric acid derivatives as matrix metalloprotease inhibitors
|
|
JPH10130217A
(ja)
|
1996-11-01 |
1998-05-19 |
Kotobuki Seiyaku Kk |
カルボン酸及びその誘導体及びその製造法並びにこれを含有する医薬組成物
|
|
GB9624817D0
(en)
|
1996-11-28 |
1997-01-15 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
US5840974A
(en)
|
1996-12-04 |
1998-11-24 |
Britisch Biotech Pharmaceuticals, Ltd. |
Metalloproteinase inhibitors
|
|
WO1998027069A1
(en)
|
1996-12-17 |
1998-06-25 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperazine compounds as inhibitors of mmp or tnf
|
|
US6077864A
(en)
|
1997-01-06 |
2000-06-20 |
Pfizer Inc. |
Cyclic sulfone derivatives
|
|
ZA9820B
(en)
|
1997-01-07 |
1998-07-02 |
Abbott Lab |
Macrocyclic inhibitors of matrix metalloproteinases and tnf x secretion
|
|
ZA9818B
(en)
|
1997-01-07 |
1998-07-02 |
Abbott Lab |
C-terminal ketone inhibitors of matrix metalloproteinases and tnf alpha secretion
|
|
US5837696A
(en)
|
1997-01-15 |
1998-11-17 |
The Research Foundation Of State University Of New York |
Method of inhibiting cancer growth
|
|
JPH10204054A
(ja)
|
1997-01-21 |
1998-08-04 |
Ono Pharmaceut Co Ltd |
フェニルスルホンアミド誘導体
|
|
JPH10204059A
(ja)
|
1997-01-22 |
1998-08-04 |
Ono Pharmaceut Co Ltd |
フェニルスルホンアミド誘導体
|
|
JP3563411B2
(ja)
|
1997-01-23 |
2004-09-08 |
エフ・ホフマン−ラ ロシュ アーゲー |
スルファミド−メタロプロテアーゼ阻害剤
|
|
GB9702088D0
(en)
|
1997-01-31 |
1997-03-19 |
Pharmacia & Upjohn Spa |
Matrix metalloproteinase inhibitors
|
|
SK112899A3
(en)
|
1997-02-26 |
2001-05-10 |
Pfizer |
Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
|
|
KR20000075681A
(ko)
|
1997-02-26 |
2000-12-26 |
그레이엄 브레레톤, 레슬리 에드워즈 |
메탈로프로테아제 억제제로서의 후위 히드록사메이트 유도체
|
|
AU748998B2
(en)
|
1997-02-27 |
2002-06-13 |
Wyeth Holdings Corporation |
N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
|
|
US6197791B1
(en)
|
1997-02-27 |
2001-03-06 |
American Cyanamid Company |
N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
|
|
US6172057B1
(en)
|
1997-02-27 |
2001-01-09 |
American Cyanamid Company |
N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
|
|
CA2281570C
(en)
|
1997-03-11 |
2003-09-23 |
Les Laboratoires Aeterna Inc. |
Composition for treating tumors containing shark cartilage extracts and anti-neoplastic agents
|
|
US6034136A
(en)
|
1997-03-20 |
2000-03-07 |
Novartis Ag |
Certain cyclic thio substituted acylaminoacid amide derivatives
|
|
JP2001518090A
(ja)
|
1997-03-28 |
2001-10-09 |
ゼネカ リミテッド |
腫瘍壊死因子の阻害に有用な複素環により置換したヒドロキサム酸
|
|
EP0973748A1
(en)
|
1997-04-01 |
2000-01-26 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
US5985900A
(en)
|
1997-04-01 |
1999-11-16 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
AT404904B
(de)
|
1997-04-03 |
1999-03-25 |
Prior Eng Ag |
Vorrichtung zur kontinuierlichen annularen chromatographie
|
|
GB9707333D0
(en)
|
1997-04-11 |
1997-05-28 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
ATE210639T1
(de)
|
1997-05-09 |
2001-12-15 |
Hoechst Ag |
Substituierte diaminocarbonsäuren
|
|
DE19719621A1
(de)
|
1997-05-09 |
1998-11-12 |
Hoechst Ag |
Sulfonylaminocarbonsäuren
|
|
AU7294098A
(en)
|
1997-05-09 |
1998-11-27 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
US5804581A
(en)
|
1997-05-15 |
1998-09-08 |
Bayer Corporation |
Inhibition of matrix metalloproteases by substituted phenalkyl compounds
|
|
GB9710490D0
(en)
|
1997-05-21 |
1997-07-16 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
EP0887077A1
(de)
|
1997-06-27 |
1998-12-30 |
Boehringer Mannheim Gmbh |
Verwendung von Azulenderivaten als Metalloproteaseinhibitoren
|
|
CA2265671A1
(en)
|
1997-07-10 |
1999-01-21 |
Daniela Jabes |
Matrix metalloproteinase inhibitors
|
|
CA2297988A1
(en)
|
1997-08-04 |
1999-02-11 |
Amgen Inc. |
Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors
|
|
DE69805473T2
(de)
|
1997-08-08 |
2003-01-16 |
Pfizer Products Inc., Groton |
Arylsulfonylaminohydroxamsäurederivate
|
|
ZA988967B
(en)
|
1997-10-03 |
2000-04-03 |
Du Pont Pharm Co |
Lactam metalloprotease inhibitors.
|
|
WO1999018079A1
(en)
|
1997-10-06 |
1999-04-15 |
Warner-Lambert Company |
Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
|
|
CN1138760C
(zh)
|
1997-10-06 |
2004-02-18 |
惠氏控股公司 |
作为基质金属蛋白酶和tace抑制剂的邻亚磺酰氨基二环杂芳基异羟肟酸的制备和用途
|
|
EP1024134A4
(en)
|
1997-10-09 |
2003-05-14 |
Ono Pharmaceutical Co |
DERIVATIVES OF AMINOBUTANIC ACID
|
|
DE69829875T2
(de)
*
|
1997-10-14 |
2006-03-09 |
Mitsubishi Pharma Corp. |
Piperazin-verbindungen und ihre medizinische verwendung
|
|
CA2308361A1
(en)
|
1997-11-12 |
1999-05-20 |
Andrew Douglas Baxter |
Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
|
|
GB9723905D0
(en)
|
1997-11-12 |
1998-01-07 |
Chiroscience Ltd |
Heterocyclic compounds having MMP and TNF inhibitory activity
|
|
WO1999024399A1
(en)
|
1997-11-12 |
1999-05-20 |
Darwin Discovery Limited |
Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
|
|
HUP0002811A3
(en)
|
1997-11-13 |
2002-11-28 |
British Biotech Pharm |
Succinamide derivative as metalloproteinase inhibitors and pharmaceutical compositions containing it
|
|
FR2771095B1
(fr)
|
1997-11-14 |
1999-12-17 |
Adir |
Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
RU2200154C2
(ru)
|
1997-12-12 |
2003-03-10 |
Дайичи Файн Кемикал Ко., Лтд. |
Новые ингибиторы металлопротеиназ
|
|
EP0922702A1
(de)
|
1997-12-13 |
1999-06-16 |
Roche Diagnostics GmbH |
Neue Azulenderivate und diese enthaltende Arzneimittel
|
|
US6107291A
(en)
|
1997-12-19 |
2000-08-22 |
Amgen Inc. |
Azepine or larger medium ring derivatives and methods of use
|
|
US6335329B1
(en)
|
1997-12-19 |
2002-01-01 |
Amgen Inc. |
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
|
|
DE69830513T2
(de)
|
1997-12-22 |
2006-03-16 |
Bayer Pharmaceuticals Corp., West Haven |
HEMMUNG DER p38 KINASE UNTER VERWENDUNG VON SYMMETRISCHEN UND ASYMMETRISCHEN DIPHENYLHARNSTOFFEN
|
|
EP1044173A4
(en)
|
1997-12-23 |
2005-03-09 |
Spectran Corp |
LARGE SCALE MANUFACTURING PROCESS OF OPTICAL FIBER PREFORMS WITH IMPROVED CHARACTERISTICS
|
|
US6071903A
(en)
|
1998-01-27 |
2000-06-06 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids
|
|
CN1293663A
(zh)
|
1998-01-27 |
2001-05-02 |
美国氰胺公司 |
为基质金属蛋白酶抑制剂的2,3,4,5-四氢-1h-[1,4]苯并二氮杂䓬-3-异羟肟酸
|
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
|
DE69934094T2
(de)
|
1998-01-30 |
2007-06-06 |
Darwin Discovery Ltd., Slough |
N-hydroxyformamid-derivate
|
|
PL342009A1
(en)
|
1998-02-04 |
2001-05-07 |
Novartis Ag |
Sulphonylamine derivatives capable to inhibit extracellular substance degrading metaloproteinases
|
|
IL137147A0
(en)
|
1998-02-06 |
2001-07-24 |
Darwin Discovery Ltd |
Hydroxamic and carboxylic acid derivatives
|
|
CN1213021C
(zh)
|
1998-02-19 |
2005-08-03 |
惠氏控股公司 |
作为基质金属蛋白酶抑制剂的 n -羟基- 2 - (烷基、芳基或杂芳基硫烷基、亚磺酰基或磺酰基 ) - 3 -取代的烷
|
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
|
DE69917124T2
(de)
|
1998-04-10 |
2005-05-12 |
Pfizer Products Inc., Groton |
Cyclobutyl-Aryloxysulfonylamin-Hydroxamsäurederivate
|
|
EP1077974A1
(en)
|
1998-05-14 |
2001-02-28 |
Du Pont Pharmaceuticals Company |
Substituted aryl hydroxamic acids as metalloproteinase inhibitors
|
|
BR9910678A
(pt)
|
1998-05-14 |
2001-10-02 |
Du Pont Pharm Co |
Composto, composição farmacêutica, método para traramento ou prevenção de uma doença inflamatória, método para tratamento de uma condição ou uma doença mediada por mmps, tnf, agrecanase, ou um composto dos mesmos, em um mamìfero, método de redução de nìveis de tnf em pacientes, sem a inibição de mmps, método para tratamento de uma condição ou uma doença e uso de um novo composto
|
|
US6288063B1
(en)
|
1998-05-27 |
2001-09-11 |
Bayer Corporation |
Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
|
|
WO1999065867A1
(en)
|
1998-06-17 |
1999-12-23 |
Du Pont Pharmaceuticals Company |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
FR2780402B1
(fr)
|
1998-06-30 |
2001-04-27 |
Adir |
Nouveaux composes acides carboxyliques et hydroxamiques inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
DE19831980A1
(de)
|
1998-07-16 |
2000-01-20 |
Hoechst Marion Roussel De Gmbh |
Sulfonylaminophosphin- und phosphonsäurederivate
|
|
US6350885B1
(en)
|
1998-07-30 |
2002-02-26 |
Warner-Lambert Company |
Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases
|
|
OA11589A
(en)
|
1998-07-30 |
2004-07-30 |
Warner Lambert Co |
Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases.
|
|
UA59453C2
(uk)
|
1998-08-12 |
2003-09-15 |
Пфайзер Продактс Інк. |
Похідні гідроксипіпеколат гідроксамової кислоти як інгібітори матричних металопротеїназ
|
|
WO2000012082A1
(en)
|
1998-08-26 |
2000-03-09 |
Glaxo Group Limited |
Formamide compounds as therapeutic agents
|
|
EP1121118A4
(en)
|
1998-08-26 |
2002-09-11 |
Glaxo Group Ltd |
FORMAMIDE-BASED THERAPEUTIC AGENTS
|
|
AU5688999A
(en)
|
1998-08-26 |
2000-03-21 |
Glaxo Group Limited |
Formamide compounds as therapeutic agents
|
|
US6479502B1
(en)
|
1998-08-29 |
2002-11-12 |
British Biotech Pharmaceuticals |
Hydroxamic acid derivatives as proteinase inhibitors
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
WO2000015603A1
(en)
|
1998-09-11 |
2000-03-23 |
Ajinomoto Co., Inc. |
Benzene derivatives and medicinal use thereof
|
|
AU5654399A
(en)
|
1998-09-22 |
2000-04-10 |
Ishihara Sangyo Kaisha Ltd. |
Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
|
|
ES2205944T3
(es)
|
1998-10-23 |
2004-05-01 |
Dow Agrosciences Llc |
Compuestos de 3-(fenil sustituido)-5-(ciclopropil sustituido)-1,2,4-triazol.
|
|
EP1004578B1
(en)
|
1998-11-05 |
2004-02-25 |
Pfizer Products Inc. |
5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
|
|
GB9826153D0
(en)
|
1998-11-27 |
1999-01-20 |
Hoffmann La Roche |
Hydrazine derivatives
|
|
CN1132819C
(zh)
|
1998-12-11 |
2003-12-31 |
霍夫曼-拉罗奇有限公司 |
作为TNF-α抑制剂的环状肼衍生物
|
|
US6372747B1
(en)
|
1998-12-18 |
2002-04-16 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
|
WO2000037433A1
(en)
|
1998-12-18 |
2000-06-29 |
Abbott Laboratories |
Inhibitors of matrix metalloproteinases
|
|
JP2002536964A
(ja)
|
1998-12-22 |
2002-11-05 |
サブサイダリー ナンバースリー インコーポレイテッド |
ヒト免疫不全ウイルスに対する遺伝子抑制エレメント
|
|
AU1836900A
(en)
|
1998-12-31 |
2000-07-24 |
Aventis Pharmaceuticals Inc. |
N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
|
|
CA2358939A1
(en)
|
1998-12-31 |
2000-07-13 |
Joseph P. Burkhart |
3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
|
|
CA2357874A1
(en)
|
1999-01-07 |
2000-07-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Cyclic compound
|
|
AU2500800A
(en)
|
1999-01-14 |
2000-08-01 |
Bruce M. Boman |
Immunoassays to detect diseases or disease susceptibility traits
|
|
FR2788525B1
(fr)
|
1999-01-19 |
2002-11-29 |
Commissariat Energie Atomique |
Pseudo-peptides phosphiniques, utilisables comme inhibiteurs des metalloproteases a zinc matricielles
|
|
US6294539B1
(en)
|
1999-01-19 |
2001-09-25 |
Advanced Syntech, Llc |
Heterocyclic hydroxamic acid derivatives as MMP inhibitors
|
|
AR022423A1
(es)
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento
|
|
US6313123B1
(en)
|
1999-01-27 |
2001-11-06 |
American Cyanamid Company |
Acetylenic sulfonamide thiol tace inhibitors
|
|
US6326516B1
(en)
|
1999-01-27 |
2001-12-04 |
American Cyanamid Company |
Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
AR022424A1
(es)
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Compuestos derivados de acidos ortosulfonamido acetilenico e hidroxamico biciclico heteroarilo amido de acido fosfinico como inhibidores tace, composicionfarmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento
|
|
BR0007784A
(pt)
|
1999-01-27 |
2002-02-05 |
American Cyanamid Co |
Composto, método para inibir mudanças patológicas mediadas pela enzima que converte o tnf-alfa (tace) em um mamìfero, composição farmacêutica, e, processo para preparar um composto
|
|
ATE280152T1
(de)
|
1999-01-27 |
2004-11-15 |
Wyeth Corp |
Acetylenische sulfonamid-thiol-tace-inhibitoren
|
|
AR035313A1
(es)
|
1999-01-27 |
2004-05-12 |
Wyeth Corp |
Inhibidores de tace acetilenicos de acido hidroxamico de sulfonamida a base de alfa-aminoacidos, composiciones farmaceuticas y el uso de los mismos para la manufactura de medicamentos.
|
|
AR035311A1
(es)
|
1999-01-27 |
2004-05-12 |
Wyeth Corp |
Derivados de acido hidroxamico que contienen alquinilo, como inhibidores de las metalloproteinasas de matriz y de la tace, composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento
|
|
US6200996B1
(en)
|
1999-01-27 |
2001-03-13 |
American Cyanamid Company |
Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
|
|
US6225311B1
(en)
|
1999-01-27 |
2001-05-01 |
American Cyanamid Company |
Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
|
|
US6277885B1
(en)
|
1999-01-27 |
2001-08-21 |
American Cyanamid Company |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
AR035478A1
(es)
|
1999-01-27 |
2004-06-02 |
Wyeth Corp |
Acido amida-hidroxamico, acido acetilenico, beta-sulfonamido y fosfinico como inhibidores de la tace, uso de los mismos para la manufactura de un medicamento y composicion farmaceutica que los contiene
|
|
AR022422A1
(es)
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Inhibidores de tace acetilenicos de acido hidroxamico de heteroarilfulfonamida y amida del acido fosfinico
|
|
WO2000046189A1
(en)
|
1999-02-02 |
2000-08-10 |
Shionogi & Co., Ltd. |
Sulfonamide derivatives having cyclic structures
|
|
AU775701B2
(en)
|
1999-02-08 |
2004-08-12 |
G.D. Searle & Co. |
Sulfamato hydroxamic acid metalloprotease inhibitor
|
|
US6177077B1
(en)
|
1999-02-24 |
2001-01-23 |
Edward L. Tobinick |
TNT inhibitors for the treatment of neurological disorders
|
|
CN1348442A
(zh)
|
1999-02-26 |
2002-05-08 |
默克公司 |
新的磺胺化合物及其应用
|
|
WO2000058280A1
(en)
|
1999-03-26 |
2000-10-05 |
Shionogi & Co., Ltd. |
Carbocyclic sulfonamide derivatives
|
|
AU3196200A
(en)
|
1999-03-26 |
2000-10-16 |
Shionogi & Co., Ltd. |
Beta-amino acid derivatives
|
|
WO2000058304A1
(en)
|
1999-03-26 |
2000-10-05 |
Shionogi & Co., Ltd. |
Heterocyclic sulfonamide derivatives
|
|
DE60003863T2
(de)
|
1999-03-31 |
2004-04-22 |
Pfizer Products Inc., Groton |
Dioxocyclopentylhydroxamsäure
|
|
EP1165500A1
(en)
*
|
1999-04-02 |
2002-01-02 |
Du Pont Pharmaceuticals Company |
Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase
|
|
PL351374A1
(en)
|
1999-04-19 |
2003-04-07 |
Shionogi & Co |
Sulfonamide derivatives having oxadiazole rings
|
|
AUPP982399A0
(en)
|
1999-04-19 |
1999-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Mmp inhibitor
|
|
AU4249700A
(en)
|
1999-04-19 |
2000-11-02 |
Sumitomo Pharmaceuticals Company, Limited |
Hydroxamic acid derivative
|
|
GB9911071D0
(en)
|
1999-05-12 |
1999-07-14 |
Darwin Discovery Ltd |
Hydroxamic and carboxylic acid derivatives
|
|
MXPA01011762A
(es)
|
1999-05-17 |
2002-04-24 |
Daiichi Fine Chem Co Ltd |
Derivados novedosos de acido hidroxamico.
|
|
EP1081137A1
(en)
|
1999-08-12 |
2001-03-07 |
Pfizer Products Inc. |
Selective inhibitors of aggrecanase in osteoarthritis treatment
|
|
GB9922825D0
(en)
|
1999-09-25 |
1999-11-24 |
Smithkline Beecham Biolog |
Medical use
|
|
US6632667B1
(en)
|
1999-10-28 |
2003-10-14 |
Isis Pharmaceuticals, Inc. |
Modulation of L-selectin shedding via inhibition of tumor necrosis factor-α converting enzyme (TACE)
|
|
GB0004153D0
(en)
|
2000-02-23 |
2000-04-12 |
Astrazeneca Uk Ltd |
Novel use
|
|
JP4798921B2
(ja)
|
2000-03-06 |
2011-10-19 |
バイオシーク インコーポレーティッド |
機能相同性スクリーニング
|
|
IL151552A0
(en)
|
2000-03-17 |
2003-04-10 |
Bristol Myers Squibb Pharma Co |
Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
|
|
ATE260272T1
(de)
|
2000-03-17 |
2004-03-15 |
Bristol Myers Squibb Pharma Co |
Beta-aminsäure-derivate zur verwendung als matrix-metalloproteasen- und tna-alpha-inhibitoren
|
|
EP1282614B1
(en)
|
2000-05-15 |
2003-11-12 |
Darwin Discovery Limited |
Hydroxamic acid derivatives
|
|
US6620823B2
(en)
|
2000-07-11 |
2003-09-16 |
Bristol-Myers Squibb Pharme Company |
Lactam metalloprotease inhibitors
|
|
US20040029928A1
(en)
|
2000-08-31 |
2004-02-12 |
Terukage Hirata |
Novel propenohydroxamic acid derivatives
|
|
ATE445400T1
(de)
|
2001-05-25 |
2009-10-15 |
Bristol Myers Squibb Co |
Hydantion-derivate als hemmer von matrix- metalloproteinasen
|
|
SE519050C2
(sv)
|
2001-05-28 |
2003-01-07 |
Fazer Ab Oy Karl |
Påfyllnadsanordning för varor
|
|
US6770647B2
(en)
|
2001-08-17 |
2004-08-03 |
Bristol-Myers Squibb Pharma Company |
Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
|
|
AU2002341715A1
(en)
|
2001-09-17 |
2003-04-01 |
Bristol-Myers Squibb Company |
Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
|